Literature DB >> 7234757

Several conditions causing elevation of serum CK-MB and CK-BB.

S H Tsung.   

Abstract

Most of the creatine kinase (CK:EC 2.7.3.2) activity is present in skeletal muscle and myocardium. However, some activity in other organs has been reported. Theoretically, the destruction of organs that contain CK activity should release soluble enzymes into the general circulation. The effects of various destructive processes on serum creatine kinase isoenzymes in 70 patients were studied. The MB isoenzyme was demonstrated in 17 of 70 patients (24%), and the BB isoenzyme in 12 of 70 patients (17%). MB activity ranged from 3 to 12 U/l, or 0.7% to 10% of the total CK activity. BB activity ranged from 2.5 to 21 U/l, or 0.4% to 18.6% of the total CK activity. Interpretation of the results of CK isoenzyme studies should be made very carefully, especially if laboratories use CK-MB methods that measure MB and BB in combination. The diagnosis of myocardial injury should never be based solely on the presence of creatine kinase MB isoenzyme in the serum, but should be supported by additional clinical and laboratory data.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7234757     DOI: 10.1093/ajcp/75.5.711

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  6 in total

1.  Cardiac enzymes in patients undergoing caesarean section.

Authors:  R M Ross; T Baker
Journal:  Can J Anaesth       Date:  1995-01       Impact factor: 5.063

2.  Serum creatine kinase isoenzyme levels in patients with cerebral tumours.

Authors:  A S David
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

3.  Total CK activity and isoenzyme patterns in normal and neoplastic tissue of gastrointestinal tract.

Authors:  S H Tsung
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

4.  Postoperative myocardial damage in patients with coronary artery disease undergoing major non cardiac surgery.

Authors:  R D Seegobin; F C Goodland; T H Wilmshurst; J Johnston; C Wainwright; J Norman; N Conway
Journal:  Can J Anaesth       Date:  1991-11       Impact factor: 5.063

Review 5.  Searching for 'omic' biomarkers.

Authors:  David Lin; Zsuzsanna Hollander; Anna Meredith; Bruce M McManus
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

6.  Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon.

Authors:  Paulin N Essone; Bayode R Adegbite; Marien J M Mbadinga; Armel V Mbouna; Fabrice Lotola-Mougeni; Ayodele Alabi; Jean R Edoa; Bertrand Lell; Abraham S Alabi; Ayola A Adegnika; Michael Ramharter; Joel F D Siawaya; Martin P Grobusch; Peter G Kremsner; Selidji T Agnandji
Journal:  Infection       Date:  2022-02-08       Impact factor: 7.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.